Research and Development

Showing 15 posts of 9607 posts found.

shutterstock_2

Over half of all US/EU regulator warnings issued to Indian and Chinese manufacturers, report finds

August 28, 2019 Manufacturing and Production, Research and Development China, India, MHRA, UK, manufacturing, pharma

Concerns have been raised concerning the integrity of the global supply chain after a report from The Pharmaceutical Journal revealed …
920x920

Sacklers could give up Purdue Pharma and settle 2,000 lawsuits for $10-12 billion, proposal says

August 28, 2019 Research and Development OxyContin, Purdue Pharma, Sackler family, opioid crisis, opioids, pharma

The Sackler family are offering to settle more than 2,000 opioid crisis lawsuits for between $10-12 billion, according to NBC. …
thomas-neff

FibroGen rocked by unexpected death of CEO Thomas B Neff

August 27, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, fibrogen, pharma

In a saddening turn of events, San Francisco-based FibroGen has announced that Thomas B Neff, its Chief Executive Officer and …

Four perspectives from life sciences companies on multichannel engagement

August 23, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Biogen, GSK, Lifesciences, Teva, healthcare, pharma

By 2020, 70% of HCPs are expected to be digital natives, whose experiences with mobile, social, and digital technologies in …
andrew_dillon

NICE Chief Sir Andrew Dillon to step down in 2020

August 22, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK pharma, UK< pharma

It’s the end of an era at the National Institute of Health and Care Excellence (NICE), the UK watchdog responsible …
gilead-sciences

Gilead challenges Government over patents on preventative HIV drug Truvada

August 22, 2019 Research and Development, Sales and Marketing AIDS, CDC, Gilead, HIV, IP, PrEP, Truvada, government, patents

Gilead is challenging the US Government’s patents on PrEP drug Truvada. The Foster City firm has submitted a challenge to …
1920px-hiv-budding-color

GSK’s two drug HIV regimen effective when administered every two months

August 22, 2019 Research and Development AIDS, GSK, HIV, ViiV Healthcare, viral supression

GSK’s long-acting, two-drug HIV regimen was as effective in supressing patient’s viral loads when administered every two months (eight weeks), …

NHS patients to receive AbbVie’s Skyrizi for plaque psoriasis following NICE recommendation

August 21, 2019 Research and Development, Sales and Marketing AbbVie, NICE, Skyrizi, pharma

AbbVie’s Skyrizi (risankizumab) has been awarded a positive recommendation from UK drug watchdog NICE, meaning that the IL-23 inhibitor will …
teva_copy

Teva launch generic version of EpiPen for children

August 21, 2019 Research and Development Mylan, Teva, allergies, children, epipen, pharma

A generic version of Mylan’s EpiPen, manufactured by Teva, is now available for children weighing between 15kg and 30kg in …
astrazeneca_building_white

AstraZeneca’s Imfinzi flops in advanced treatment-naive non-small cell lung cancer

August 21, 2019 Research and Development AstraZeneca, Cancer, Imfinzi, lung cancer, pharma

New data have emerged illustrating that AstraZeneca’s anti-CTLA4 antibody Imfinzi (durvalumab) failed to meet its primary endpoint when used in …
blood-1813410_960_720

NHS England to fund Hemlibra for patients with severe haemophilia

August 21, 2019 Research and Development Chugai, Hemlibra, Roche, haemophilia, pharma

NHS England is to fund Roche and Chugai Pharma UK’s haemophilia drug Hemlibra, for people with sever congenital haemophilia A …

Novartis exec pushed out over Zolgensma data scandal denies wrongdoing

August 21, 2019 Research and Development AveXis, FDA, Novartis, Zolgensma, data scandal, pharma, sma

Dr Brian Kaspar, the Novartis exec pushed out of AveXis over the Zolgensma data scandal, has said in a statement …
733px-reduction_gear

Finding the needle in the haystack of rare disease

August 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Genomenon, Rare Genomics Institute, pharma, rare disease

Through the use of Genomenon’s AI-driven Mastermind Genomic Search Engine, the Rare Genomics Institute succeeded where a leading genetics laboratory …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

August 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Air pollution, CAR-T therapy, HIV, Kymriah, Medicare, Novartis, Yescarta, Zolgensma

Novartis’ faulty data scandal dominated the headlines this week, as the Swiss firm faced fierce backlash over covering up the …
The Gateway to Local Adoption Series

Latest content